TotalMarketCap

Summit Therapeutics

SMMTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$14.067 B

$17.59 +2.45%

Close of 12 Oct 2026

As of 12 Oct 2026, Summit Therapeutics (SMMT) has a market capitalization of $14.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3630 by revenue

Earnings

-$1.08B

Loss-making

Shares outstanding

797,749,602

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #26Ascendis Pharma A/SASND$15.1B
  2. #27Jazz PharmaceuticalsJAZZ$14.2B
  3. #28Summit TherapeuticsSMMT$14.1B
  4. #29Corcept TherapeuticsCORT$13.1B
  5. #30BridgeBio PharmaBBIO$12.8B

What if Summit Therapeutics were worth as much as…

Open the what-if tool →

Gold $29.0T

$36,293.23

Per share 2,063× higher

Bitcoin $1.66T

$2,079.44

Per share 118× higher

Nvidia $5.53T

$6,909.42

Per share 393× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Summit Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 13 Oct 2026. Read the methodology.